Back to Search
Start Over
Infectious Disease Alert Updates.
- Source :
-
Infectious Disease Alert . Jan2023, Vol. 42 Issue 4, p1-12. 12p. - Publication Year :
- 2023
-
Abstract
- The article discusses the retrospective cohort study performed at the Mayo Clinic in Minnesota from February to June 2022, the first peer-reviewed publication demonstrating the efficacy of the monoclonal antibody bebtelovimab in the prevention of severe COVID-19 infection compared with nirmatrelvir/ritonavir. It mentions that the Food and Drug Administration has issued emergency use authorizations for six new monoclonal antibodies in the fight against SARS-CoV-2.
Details
- Language :
- English
- ISSN :
- 07397348
- Volume :
- 42
- Issue :
- 4
- Database :
- Academic Search Index
- Journal :
- Infectious Disease Alert
- Publication Type :
- Periodical
- Accession number :
- 160869347